CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome? Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Association Between Functional Impairment and Medication Burden in Adults with Heart Failure The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Heart Failure Outcomes With Volume-Guided Management

Original Research2020 Dec 10;S1936-878X(20)31001-9.

JOURNAL:JACC Cardiovasc Imaging. Article Link

Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure

B Tayal, D Debs, F Nabi et al. Keywords: myocardial scar; cardiovascular magnetic resonance; secondary MR; mitral regurgitation volume; mitral regurgitation fraction; HF; LV

Full Text PDF